Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET
Company Participants
Paul Goodson – IR
Wenbin Jiang – CEO
William McCombe – CFO
Conference Call Participants
David Westenberg – Piper Sandler
Chad Wiatrowski – TD Cowen
Andrew Cooper – Raymond James
Operator
Thank you for standing by. At this time, I would like to welcome everyone to the Cytek Biosciences First Quarter 2025 Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Paul Goodson, Head of Investor Relations. Please go ahead, sir.
Paul Goodson
Thank you, operator. Earlier today, Cytek Biosciences released financial results for the first quarter ended March 31, 2025. If you haven’t received this news release or if you’d like to be added to the company’s distribution list, please send an e-mail to [email protected].
A copy of the news release is also available on the Investor Relations section of Cytek’s website at investors.cytekbio.com. Joining me today from Cytek are Wenbin Jiang, CEO; and Bill McCombe, CFO. Please note that we will be referencing a slide presentation during the call today that has been posted to the Investors section of our corporate website.
As a reminder, we will make statements during the call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding Cytek’s business plans, strategies, opportunities and financial projections. These statements are based on the company’s current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated in these statements.
Additional information regarding these risks and uncertainties appears in our slide presentation in the section entitled Forward-Looking Statements, in the press release Cytek issued today, and in Cytek’s filings with the SEC. This call will also include a discussion of certain
Read the full article here